Caricamento...
Amongst eligible patients, age and comorbidity do not predict for dose limiting toxicity from phase I chemotherapy
BACKGROUND: There are no clear predictors clinicians can use to determine who is more likely to experience dose limiting toxicity (DLT) in phase I chemotherapy clinical trials. Many providers are reluctant to refer older adults to phase I trials because of concerns about the development of toxicity....
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2809128/ https://ncbi.nlm.nih.gov/pubmed/19649630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1084-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|